Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
University of California, San Diego, La Jolla, California University California, Los Angeles, Los Angeles, California Hem-Onc Associates of the Treasure Coast, Port Saint Lucie, Florida Moffitt Cancer Center, Tampa, Florida Emory University, Atlanta, Georgia Massachusetts General Hospital, Boston, Massachusetts Washington University School of Medicine, St Louis, Missouri New York Cancer and Blood Specialists, Port Jefferson Station, New York